 | Up a level |
Weickert, Thomas W; Jacomb, Isabella; Lenroot, Rhoshel; Lappin, Julia; Weinberg, Danielle; Brooks, William S; Brown, David; Pellen, Daniel; Kindler, Jochen; Mohan, Adith; Wakefield, Denis; Lloyd, Andrew R; Stanton, Clive; O'Donnell, Maryanne; Liu, Dennis; Galletly, Cherrie; Shannon Weickert, Cynthia (2024). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, behavior, and immunity, 115, pp. 191-200. Elsevier 10.1016/j.bbi.2023.10.012
